1. Home
  2. WVE vs KGS Comparison

WVE vs KGS Comparison

Compare WVE & KGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • KGS
  • Stock Information
  • Founded
  • WVE 2012
  • KGS 2011
  • Country
  • WVE Singapore
  • KGS United States
  • Employees
  • WVE N/A
  • KGS N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • KGS
  • Sector
  • WVE Health Care
  • KGS
  • Exchange
  • WVE Nasdaq
  • KGS Nasdaq
  • Market Cap
  • WVE 2.4B
  • KGS 2.6B
  • IPO Year
  • WVE 2015
  • KGS 2023
  • Fundamental
  • Price
  • WVE $13.67
  • KGS $36.44
  • Analyst Decision
  • WVE Strong Buy
  • KGS Strong Buy
  • Analyst Count
  • WVE 10
  • KGS 11
  • Target Price
  • WVE $21.30
  • KGS $34.64
  • AVG Volume (30 Days)
  • WVE 1.4M
  • KGS 643.2K
  • Earning Date
  • WVE 11-12-2024
  • KGS 11-06-2024
  • Dividend Yield
  • WVE N/A
  • KGS 4.50%
  • EPS Growth
  • WVE N/A
  • KGS N/A
  • EPS
  • WVE N/A
  • KGS 0.26
  • Revenue
  • WVE $53,610,000.00
  • KGS $1,075,772,000.00
  • Revenue This Year
  • WVE N/A
  • KGS $37.82
  • Revenue Next Year
  • WVE N/A
  • KGS $15.27
  • P/E Ratio
  • WVE N/A
  • KGS $140.31
  • Revenue Growth
  • WVE N/A
  • KGS 33.77
  • 52 Week Low
  • WVE $3.50
  • KGS $17.50
  • 52 Week High
  • WVE $16.74
  • KGS $36.99
  • Technical
  • Relative Strength Index (RSI)
  • WVE 50.96
  • KGS 75.08
  • Support Level
  • WVE $14.95
  • KGS $31.00
  • Resistance Level
  • WVE $16.71
  • KGS $36.99
  • Average True Range (ATR)
  • WVE 1.04
  • KGS 1.08
  • MACD
  • WVE -0.28
  • KGS 0.31
  • Stochastic Oscillator
  • WVE 14.72
  • KGS 90.73

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About KGS Kodiak Gas Services Inc.

Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Compression Operations and Other Services. Compression Operations consist of operating company-owned and customer-owned compression infrastructure for customers, pursuant to fixed-revenue contracts to enable the production, gathering and transportation of natural gas and oil. Other Services consist of a full range of contract services to support the needs of customers, including station construction, maintenance and overhaul and other ancillary time and material-based offerings.

Share on Social Networks: